Literature DB >> 13802132

The clinical response and the amount of insulin extractable from the pancreas in diabetic patients treated with oral hypoglycaemic drugs: a report on five cases.

A BOGOCH, T W DAVIS, E JOW, G A WRENSHALL.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS/pharmacology; INSULIN/physiology; PANCREAS/physiology

Mesh:

Substances:

Year:  1959        PMID: 13802132      PMCID: PMC1831366     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Insulin extractable from the pancreas and islet cell histology; comparative studies in spontaneous diabetes in dogs and human subjects.

Authors:  G A WRENSHALL; W S HARTROFT; C H BEST
Journal:  Diabetes       Date:  1954 Nov-Dec       Impact factor: 9.461

2.  Experience with glipasol (R. P. 2259)-an antidiabetic sulfonamide drug.

Authors:  T W DAVIS; R B KERR; A BOGOCH
Journal:  Can Med Assoc J       Date:  1959-07-15       Impact factor: 8.262

3.  Physical binding of insulin by gamma globulins of insulin-resistant subjects.

Authors:  B A BURROWS; T PETERS; F C LOWELL
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

4.  Sex differences in the amount of insulin extractable from diabetic human pancreas.

Authors:  G A WRENSHALL; J D HAMILTON
Journal:  Ann N Y Acad Sci       Date:  1957-07-10       Impact factor: 5.691

5.  Clinical experience with sulfonylurea compounds in diabetes.

Authors:  A MARBLE; R CAMERINI-DAVALOS
Journal:  Ann N Y Acad Sci       Date:  1957-07-10       Impact factor: 5.691

6.  Experience with the tolbutamide treatment of five hundred cases of diabetes on an ambulatory basis.

Authors:  H DOLGER
Journal:  Ann N Y Acad Sci       Date:  1957-07-10       Impact factor: 5.691

7.  Diabetes following total pancreatectomy; clinical observations of ten cases.

Authors:  E P McCULLAGH; J R COOK; E K SHIREY
Journal:  Diabetes       Date:  1958 Jul-Aug       Impact factor: 9.461

8.  The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.

Authors:  D DIENGOTT; H DOLGER; I A MIRSKY
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

9.  Insulin antagonists, insulin antibodies and insulin resistance.

Authors:  S A BERSON; R S YALOW
Journal:  Am J Med       Date:  1958-08       Impact factor: 4.965

  9 in total
  1 in total

1.  PERFORMANCE IN EXAMINATIONS.

Authors:  A HUSAROVA
Journal:  Br Med J       Date:  1963-09-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.